Karen Davies
Diagnostics R&D & Chief TechnologistMs. Karen Davies is Diagnostics R&D & Chief Technologist of OraSure Technologies, Inc. from 2025. Ms. Karen Davies was Senior Vice President of Research & Development of OraSure Technologies, Inc. from 2025 until 2025. She is Chief Development Officer of Sherlock Biosciences, Inc. from April 2022. She has medical diagnostics and device development experience, honed at organizations including Gen-Probe, Abbott, Dura Pharmaceuticals and Quidel. While at Quidel, Karen served as Vice President of Instrument Systems, where she was responsible for product architecture and development, as well as Vice President of Business Transformation, where she was responsible for internal process improvement and global commercial communications associated with M&A transactions. Over her career, Karen has held key leadership roles as part of launch teams for multiple diagnostic platforms, from the central lab to point-of-care and over-the-counter to consumers. Ms. Davies holds a Bachelor of Science degree in Mechanical Engineering from Stanford University.
Positions
- Company NameOraSure Technologies, Inc.Stock CodeOSURPositionDiagnostics R&D & Chief TechnologistColleagues
- CECarrie Eglinton MannerPresident, CEO & Director
- JPJohn Patrick KennyIndependent Chairman
- KJKenneth J. McGrathChief Financial Officer
- MAMichele AnthonySenior VP, Chief Accounting Officer, Controller & Assistant Secretary
- RIRafal IwasiowSample Management Solutions R&D & Chief Scientist
- NJNancy J. GaglianoIndependent Director
- RWRobert W. McMahonIndependent Director
- LMLelio MarmoraIndependent Director
